sulfalene has been researched along with Disease Models, Animal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Fukushima, K; Kanazawa, H; Kawahara, T; Kawakami, T; Masuda, M; Oishi, K; Suzuki, T; Takahashi, S; Takahashi, T; Takano, M; Tanaka, H | 1 |
| Song, CM; Wang, H; Wu, B | 1 |
| Davidson, DE; Hickman, RL; Johnsen, DO; Kinnamon, KE; Tanticharoenyos, P | 1 |
| Matuschka, FR | 1 |
5 other study(ies) available for sulfalene and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model.
Topics: Administration, Oral; Animals; Bifidobacterium; Cytokines; Disease Models, Animal; Female; Gene Expression Profiling; Influenza A Virus, H1N1 Subtype; Killer Cells, Natural; Lung; Mice, Inbred BALB C; Orthomyxoviridae Infections; Probiotics; Spleen; Sulfalene; Survival Analysis | 2015 |
[Effects of bificobacterium longum on neonatal rat model of necrotizing enterocolitis and roles of platelet-activating factor and tumor necrosis factor-alpha].
Topics: Animals; Animals, Newborn; Disease Models, Animal; Enterocolitis, Necrotizing; Female; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Sulfalene; Tumor Necrosis Factor-alpha | 2007 |
Evaluating new antimalarial drugs against trophozoite induced Plasmodium cynomolgi malaria in rhesus monkeys.
Topics: Amodiaquine; Animals; Antimalarials; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Tolerance; Haplorhini; Macaca mulatta; Malaria; Phenanthrenes; Primaquine; Prodigiosin; Pyrimethamine; Quinine; Sulfadiazine; Sulfadimethoxine; Sulfalene; Trimethoprim | 1976 |
The effect of sulfomethoxypyrazine-pyrimethamine therapy on the fine structure of Toxoplasma gondii-cysts in the brain of Mastomys natalensis. Scanning and transmission electron microscopical investigations.
Topics: Animals; Brain; Disease Models, Animal; Drug Therapy, Combination; Female; Male; Mammals; Pyrimethamine; Sulfalene; Sulfanilamides; Toxoplasma; Toxoplasmosis | 1977 |